| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.4× | −1.7× | |
| Price / Book | 2.4× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −0.0× | −1.6× | |
| EV / EBITDA | −0.7× | −1.2× | |
| Earnings yield | −70.5% | −14.3% | |
| Free cash flow yield | −62,636.9% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,285.37 | +3.63% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.24 | +2.15% | $624.74B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.95 | +2.22% | $510.61B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.57 | +3.12% | $376.6B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.24 | +3.21% | $365.73B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.65 | +2.30% | $283.25B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.86 | +2.99% | $261.89B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $687.75 | +1.23% | $254.29B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $438.94 | +3.29% | $237.3B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.47 | +2.22% | $194.02B | 22.3× | 37.5% | +29.9% |
